Snake venom toxins from Naja melanoleuca

Naja melanoleuca (Forest Cobra) venom is a complex biochemical cocktail primarily composed of proteins and peptides that function synergistically to immobilize and digest prey [1.1.3, 1.2.5]. The most significant components are three-finger toxins (3FTxs), which account for approximately 57-60% of the venom and include potent alpha-neurotoxins that target nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction [1.1.1, 1.2.1]. Binding to these receptors leads to neuromuscular blockade, resulting in progressive paralysis and potentially fatal respiratory arrest [1.2.4, 1.4.1]. The venom also contains phospholipase A2 (PLA2) enzymes (~13%), which contribute to neurotoxicity and myotoxicity, and cytotoxins that cause localized tissue damage and cardiotoxicity [1.2.2, 1.4.3]. Other components include snake venom metalloproteinases (SVMPs) and Kunitz-type inhibitors that interfere with coagulation and tissue integrity [1.2.1, 1.2.3]. In clinical medicine, these toxins are the primary targets for polyvalent antivenoms, such as the SAIMR Polyvalent Antivenom, which employ purified antibodies to neutralize the venom's lethal effects [1.2.1, 1.3.1]. Small molecule inhibitors like varespladib are also being investigated to target specific enzymatic components like PLA2 [1.4.1]. Beyond their toxicological role, individual components of Naja melanoleuca venom are utilized as high-affinity probes in neurobiology research and are being investigated as leads for novel therapeutics targeting ion channels and inflammatory pathways [1.1.2, 1.2.4].

Other names

Forest cobra venomNaja melanoleuca venomBlack cobra venom

Antibody-mediated neutralization of alpha-neurotoxins and other toxic proteins; competitive inhibition of phospholipase A2 and metalloproteinase enzymatic activities.